Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

Abstract Background and objective To evaluate the cost-effectiveness of new anticoagulants and warfarin in the prevention of stroke in Chinese patients with atrial fibrillation (AF). Methods The Markov model was constructed to compare patients’ quality-adjusted life-years (QALYs) using drug cost, th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hongtao Wei, Can Cui, Xiangli Cui, Yi Liu, Dandan Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-01-01
coleção:	BMC Health Services Research
Assuntos:	Warfarin Cost‐effectiveness New oral anticoagulants Chinese population
Acesso em linha:	https://doi.org/10.1186/s12913-021-06084-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!